Back to search

Article

ALCAM: A Novel Surface Marker on EpCAMlow Circulating Tumor Cells

2022-07-12

Abstract excerpt

<h4>Background: </h4> Current strategies in circulating tumor cell (CTC) isolation in pancreatic cancer heavily rely on the EpCAM and cytokeratin cell status. EpCAM is generally not considered as a good marker given its transitory change during Epithelial to Mesenchymal Transition (EMT) or reverse EMT. There is a need to identify other surface markers to capture the complete repertoire of PDAC CTCs. The primary ob...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
be6b2b5a-c52d-5cf4-9960-c717348925e7
DOI
10.20944/preprints202207.0178.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
ALCAM: A Novel Surface Marker on EpCAMlow Circulating Tumor CellsDOI 10.20944/preprints202207.0178.v1
Select a neighboring publication to make it the new centre.